High medication costs remain a significant barrier, with the average price of GLP-1 drugs reaching USD 1,200 per month, making them inaccessible to many
These trends are consistent with first-time prescribing rates seen around the holidays in previous years
Glucosamine also contributes to improved mobility and flexibility , making it a key ingredient in managing osteoarthritis symptoms and supporting long-term joint function
We emphasize the importance of personalized treatment plans
Friday: The FDA Drops the Hammer On February 6th, one day after the HIMS launch, FDA Commissioner Martin Makary issued a statement that may be the most consequential regulatory action in the compounded GLP-1 saga to date
3 Introduction/background: a novel dual incretin analog Despite historical research stating GIP did not assist in lowering blood glucose even with supratherapeutic levels, the success of GLP-1 RAs has led to the approval of a novel GLP-1/GIP RA, tirzepatide [42]